Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.96 USD | +1.22% | +8.16% | -8.30% |
May. 31 | Exelixis Insider Bought Shares Worth $8,733,955, According to a Recent SEC Filing | MT |
May. 20 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.30% | 6.32B | |
+14.90% | 118B | |
+13.00% | 106B | |
-3.07% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-16.93% | 15.56B | |
+4.67% | 13.63B | |
+28.46% | 12.27B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis Insider Sold Shares Worth $1,485,853, According to a Recent SEC Filing